from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2602/vapC41

LFCtreatmentdescriptionclass of inhibitor

-0.292

Amikacinug/mL Amikacintranslation

-0.158

Cap5-10ug/mL Capreomycintranslation

0.233

Rox10-50 ug/mL Roxithromycintranslation

0.118

SM2-5 ug/mL Streptomycintranslation

0.277

Tet5-10 ug/mL Tetracyclinetranslation

0.069

Rif0.2-5ug/mL Rifampicintranscription

-0.560

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.744

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.126

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.188

CPZ10-50 ug/mL Chlorpromazinerespiration

0.538

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.353

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.464

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.818

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.637

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.209

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.185

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.054

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.559

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.259

KCN5-20 ug/mL Potassium cyaniderespiration

-1.018

NaN30.2-2 mM Sodium aziderespiration

0.747

Nigericin50 uM Nigericinrespiration

1.647

TRC10-150 ug/mL Triclosanrespiration

0.822

TRZ10-25 ug/mL Thioridazinerespiration

1.931

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.268

menadione6-10 ug/mL Menadionerespiration

-0.432

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.661

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.302

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.795

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.202

NRP_1Non-replicating persistence stage 1dosRassociated

-0.466

Amp0.2mg/mL AmpicillincellWall

-0.281

Cephalexin20-100 ug/mL CephalexincellWall

-0.275

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.272

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.225

EMB10-20 ug/mL EthambutolcellWall

-0.419

Eta12-40 ug/mL EthionamidecellWall

-0.680

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.269

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.229

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.217

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.301

BZA0.12 mg/mL BenzamidearomaticAmides

-0.056

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.198

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.056

H2O24 mM hydrogen peroxideDNAdamaging

-0.630

Levo10 ug/mL LevofloxacinDNAdamaging

-0.361

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.560

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.849

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.596

UVUV-irradiationDNAdamaging

1.479

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.593

Antimycin12.5-50 ug/mL Antimycin A?

-0.618

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.164

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.639

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.567

PA8240.2-2 ug/mL PA-824?

0.708

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.005

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.581

Verapamil50 uM Verapamil?

-0.124

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.414

methoxatin10-20 ug/mL Methoxatin?